BlackRock’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

BlackRock’s Portfolio ASPX Stock Details ASPX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-259	Closed	-$26K	–	3351
2015 Q1	$26K	Hold	259	–	–	﹤0.01%	2242
2014 Q4	$14K	Hold	259	–	–	﹤0.01%	2579
2014 Q3	$7K	Buy	+259	New	+$5.51K	﹤0.01%	2984
2014 Q2	–	Sell	-218	Closed	-$7K	–	3296
2014 Q1	$7K	Buy	+218	New	+$5.86K	﹤0.01%	2975

BlackRock's ASPX Position: Q2 2015 in Review

BlackRock sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 259 shares — an estimated $26K sold.

BlackRock first reported a position in ASPX in Q1 2014 and held it in 4 quarters. The position peaked at $26K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

BlackRock reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
BlackRock sold 259 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $26K.
BlackRock first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 4 quarters.
BlackRock's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $26K in Q1 2015.
0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on BlackRock's 13F filing for Q2 2015, filed 7 Aug 2015.